ChronoScale Holdings Corporation CHRN
19.85
(2.00)
(9.15%)
as of 25 Sep
- Market cap
- $3.1B
- P/E
- 0.0×
Follow CHRN
Insider Buys
alert about insiders buying in the last 12 month
| May '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
— | 0.00 | 0.00 | 0.00 |
+8 more quarters Free account |
P/S ratio |
— | 3.28 | 0.25 | 0.16 | |
P/FCF ratio |
— | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
— | (17.87) | (4.84) | (54.11) | |
P/B ratio |
— | 18.16 | 2.32 | 1.39 | |
Price to Tangible BV |
— | 0.00 | 4.11 | 2.63 | |
EV/Sales |
— | 3.16 | 0.27 | 0.16 | |
EV/EBITDA |
— | 0.00 | 0.00 | 0.00 | |
EV/Operating CF |
— | (3.60) | (1.70) | (1.26) | |
EV/FCF |
— | (3.53) | (1.67) | (1.24) | |
Quick Ratio |
— | 0.94 | 0.98 | 0.98 | |
Current Ratio |
— | 1.55 | 1.63 | 1.66 | |
Net Debt/EBITDA |
— | 0.27 | (0.40) | (0.28) | |
Debt/Assets |
0.00% | 13.19% | 13.95% | 13.88% | |
Debt/Equity |
— | 0.45 | 0.31 | 0.31 | |
Asset Turnover |
0.00 | 1.18 | 3.55 | 3.49 | |
Operating CF/Net income |
— | 0.31 | 0.93 | 0.17 | |
Capex/Depreciation |
— | 0.00 | (0.28) | (0.02) | |
Interest Coverage |
— | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
— | 27.23% | 20.41% | 13.01% | |
Selling, General and Administrative Expense of Revenue |
— | 285.33% | 176.40% | 80.46% | |
Intangible Assets out of Total Assets |
0.00 | 0.20 | 0.20 | 0.21 | |
Share Based Compensation of Revenue |
— | 5.32% | 24.94% | 50.96% | |
Graham Net Nets |
— | 0.00 | 0.14 | 0.21 | |
Graham Number |
— | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
— | (50.52%) | (4.31%) | (11.93%) | |
Free Cash Flow Yield |
— | (27.31%) | (64.40%) | (82.09%) | |
Revenue per Share |
— | 0.60 | 1.29 | 1.62 | |
Operating CF per Share |
— | (0.60) | (1.79) | (0.09) | |
Capex per Share |
— | 0.00 | (0.05) | 0.50 | |
Free Cash Flow per Share |
— | (0.60) | (1.84) | 0.41 | |
Cash per Share |
— | 1.12 | 0.48 | 1.04 | |
Shareholders Equity per Share |
— | 1.61 | 3.72 | 3.70 | |
Interest Debt per Share |
— | 0.00 | 0.00 | 0.00 | |
Book value per Share |
— | 1.61 | 3.72 | 3.70 | |
Free Cash Flow |
— | (2.12) | (4.46) | 1.07 | |
Working Capital |
— | 4.96 | 5.41 | 5.86 | |
Capital Expenditures |
— | — | (0.13) | 1.31 | |
Net Current Asset Value |
— | 0.13 | 2.97 | 2.81 | |
EV/EBIT |
— | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
— | 0.00 | 0.04 | (0.31) | |
Net Profit Margin |
— | (321.58%) | (148.85%) | (33.62%) | |
Price to Operating Income |
— | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
— | 5.50 | 7.27 | 6.51 | |
Average Payables |
— | 2.05 | 1.49 | 1.73 | |
Average Inventory |
— | 4.81 | 4.70 | 5.03 | |
Average Assets |
11.58 | 9.83 | 23.71 | 24.16 | |
Average Common Equity |
— | 7.39 | 10.87 | 12.27 |
Columns are period end dates